MARSHALL WACE, LLP

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1318757 LONDON, X0

Position in PACB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$274,918

+$167,602 QoQ

Shares Held

163,642

+101.3% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#65

of 222 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. PACB ranks #57 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,918	163,642	+101.3%	Shares	Other	2026-08-13
2026-03-31	$107,316	81,300	+59.7%	Shares	Other	2026-05-15
2024-12-31	$93,147	50,900	-97.6%	Shares	Other	2025-02-13
2024-09-30	$3,607,264	2,121,920	+31.7%	Shares	Other	2024-11-14
2024-06-30	$2,207,481	1,611,300	+226.6%	Shares	Other	2024-08-14
2024-03-31	$1,850,002	493,334	+242.4%	Shares	Other	2024-05-15
2023-12-31	$1,413,503	144,088	-70.5%	Shares	Other	2024-02-14
2023-09-30	$4,078,707	488,468	+4147.5%	Shares	Other	2023-11-14
2023-03-31	$133,170	11,500	-84.7%	Shares	Other	2023-05-15
2022-12-31	$614,318	75,100	-16.2%	Shares	Other	2023-02-14
2022-09-30	$520,576	89,600	-38.6%	Shares	Other	2022-11-14
2020-09-30	$1,441,069	146,005	-1.5%	Shares	Sole	2020-11-16
2020-06-30	$511,500	148,261	-20.6%	Shares	Sole	2020-08-13
2020-03-31	$571,048	186,617	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.